Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 3 (Reuters)- 
             Taisho Pharmaceutical Holdings Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               69.07               63.88           280.50    
                   (+8.1 pct)          (-14.8 pct)      (+4.6 pct)  
  Operating            5.25                2.68            16.00    
                   (+96.3 pct)         (-71.5 pct)      (+48.9 pct) 
  Recurring            9.25                4.03            20.00    
                  (+129.2 pct)         (-63.7 pct)      (+8.6 pct)  
  Net                  5.75                1.18            12.00    
                  (+387.6 pct)         (-80.5 pct)      (-8.6 pct)  
  EPS               70.16 yen           14.78 yen       146.26 yen  
  EPS Diluted       70.08 yen           14.75 yen                   
  Ann Div                              100.00 yen       100.00 yen  
  -Q2 div                               50.00 yen        50.00 yen  
  -Q4 div                               50.00 yen        50.00 yen  
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news